27
2023
-
09
Good News｜Shandong Yumankun Biotechnology Co., Ltd. won the eighth batch of national centralized purchasing of pharmaceutical products.
Classification:
News
Company News
Shandong Yumangkun Biotechnology Co., Ltd. has been selected for the eighth batch of national centralized procurement of drugs organized by the Joint Purchasing Office. According to the rules of this centralized procurement, the procurement cycle of the proposed winning product is from the date of execution of the winning result to December 31, 2025.
Levocanidin is a natural substance in the body that is necessary for energy metabolism in mammals, and its main function is to promote lipid metabolism. It both brings long-chain fatty acids into the mitochondrial matrix and promotes their oxidative breakdown to provide energy to the cells, and exports short-chain lipoyl groups produced in the mitochondria. Supplementation of levocanidin can alleviate the fat metabolism disorders, dysfunction of skeletal muscle and cardiac muscle and other tissues caused by its deficiency in the body. It is suitable for chronic renal failure long-term hemodialysis patients with a series of complication symptoms due to secondary carnitine deficiency, clinical manifestations such as cardiomyopathy, skeletal myopathy, arrhythmia, hyperlipidemia, as well as hypotension and myoclonus in dialysis.
Through centralized purchasing, we can obtain more preferential prices and better supply guarantees to ensure a stable supply of drugs. At the same time, we will ensure timely delivery of goods and reliability of quality in strict accordance with relevant regulations. Through this centralized purchasing, we will provide high quality levocanidin injection to medical institutions and provide strong support for patients' treatment.
Related News
2023-11-08
On November 6, the ninth batch of national drug centralized volume purchasing meeting was held in Shanghai. Shandong Yumangkun Biotechnology Co., Ltd. consistency evaluation over the evaluation of the product piracetam injection was selected.
2023-09-27
Good News｜Shandong Yumankun Biotechnology Co., Ltd. won the eighth batch of national centralized purchasing of pharmaceutical products.
2023-09-09
Circular of the National Medical Security Bureau on Further Deepening the Intelligent Audit and Monitoring of the Medical Security Fund
2023-08-30
Notice on the Filling of Information on Drugs Related to the Ninth Batch of Centralized Purchasing of Drugs by State Organizations
Address: Room 2602, Huiyuan Building, 38 Huaneng Road, Lixia District, Jinan City, Shandong Province
©Shandong Yumankun Biotechnology Co., Ltd.